Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Shigella virulence protein VirG is a broadly protective antigen and vaccine candidate

2 Jan 2024

Abstract excerpt

Diarrhea caused by Shigella has been associated with high morbidity and mortality in young children worldwide. There are no licensed vaccines, and those clinically advanced have restricted coverage as they elicit serotype-specific immunity while disease is caused by multiple circulating serotypes. Our group had previously reported a close association between serum antibodies to the Shigella virulence factor VirG...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibiotic Resistance in Bacteria
Share to Escherichia coli research studies
Share to Viral gastroenteritis research and epidemiology

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38167387
DOI: 10.1038/s41541-023-00797-6

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Shigella virulence protein VirG is a broadly protective antigen and vaccine candidatePMID 38167387Read ↗

A broad spectrum Shigella vaccine based on VirG53–353 multiepitope region produced in a cell-free systemSemantic proximity Read ↗

Status of vaccine research and development for ShigellaSemantic proximity Read ↗

The identification of novel immunogenic antigens as potential Shigella vaccine componentsSemantic proximity Read ↗

Towards establishing a correlate of protection against shigellosis: assessing immunological endpoints across immune responses to the Shigella sonnei 1790GAHB GMMA investigational vaccineSemantic proximity Read ↗

Vaccinomics-aided next-generation novel multi-epitope-based vaccine engineering against multidrug resistant Shigella Sonnei: Immunoinformatics and chemoinformatics approachesSemantic proximity Read ↗

Towards establishing correlates of protection against shigellosis: assessing immunological endpoints across immune responses to the Shigella sonnei Generalized Modules for Membrane Antigens (GMMA) candidate vaccine (1790GAHB).Semantic proximity Read ↗

Exploring the Role of GMMA Components in the Immunogenicity of a 4-Valent Vaccine against ShigellaSemantic proximity Read ↗

Vaccines Against Shigella and Enterotoxigenic Escherichia coli: A summary of the 2018 VASE ConferenceSemantic proximity Read ↗

Towards a Four-Component GMMA-Based Vaccine against ShigellaSemantic proximity Read ↗

A Novel Shigella Proteome Microarray Discriminates Targets of Human Antibody Reactivity following Oral Vaccination and Experimental ChallengeSemantic proximity Read ↗

The Shigella Vaccines PipelineSemantic proximity Read ↗

Epitope-Based Multimeric Subunit Vaccine (ATOMSSUISpenta) Confers Cross-Protection Against Streptococcus suis InfectionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.